Severe acute kidney injury and multiple myeloma: Evaluation of kidney and patient prognostic factors

Kyle, 2004, Multiple myeloma, N Engl J Med, 351, 1860, 10.1056/NEJMra041875 Sant, 2010, Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project, Blood, 116, 3724, 10.1182/blood-2010-05-282632 Korbet, 2006, Multiple myeloma, J Am Soc Nephrol, 17, 2533, 10.1681/ASN.2006020139 Eleutherakis-Papaiakovou, 2007, Renal failure in multiple myeloma: incidence, correlations, and prognostic significance, Leuk Lymphoma, 48, 337, 10.1080/10428190601126602 Haynes, 2010, Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre, Nephrol Dial Transplant, 25, 419, 10.1093/ndt/gfp488 Rota, 1987, Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients, Medicine (Baltimore), 66, 126, 10.1097/00005792-198703000-00004 Leung, 2008, Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains, Kidney Int, 73, 1282, 10.1038/ki.2008.108 Katagiri, 2011, Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis, Nephron Clin Pract, 117, c28, 10.1159/000319644 Tsakiris, 2010, Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study, Nephrol Dial Transplant, 25, 1200, 10.1093/ndt/gfp679 Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KDIGO clinical practice guideline for acute kidney injury, Kidney Int Suppl, 2, 8 International Myeloma Working Group, 2003, Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group, Br J Haematol, 121, 749, 10.1046/j.1365-2141.2003.04355.x Greipp, 2005, International staging system for multiple myeloma, J Clin Oncol, 23, 3412, 10.1200/JCO.2005.04.242 Dimopoulos, 2010, Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group, J Clin Oncol, 28, 4976, 10.1200/JCO.2010.30.8791 Ludwig, 2010, Survival and years of life lost in different age cohorts of patients with multiple myeloma, J Clin Oncol, 28, 1599, 10.1200/JCO.2009.25.2114 Perosa, 2009, Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count, Blood Cells Mol Dis, 42, 71, 10.1016/j.bcmd.2008.09.003 Alexanian, 1990, Renal failure in multiple myeloma. Pathogenesis and prognostic implications, Arch Intern Med, 150, 1693, 10.1001/archinte.1990.00040031693017 Bladé, 1998, Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution, Arch Intern Med, 158, 1889, 10.1001/archinte.158.17.1889 Kyle, 2003, Review of 1027 patients with newly diagnosed multiple myeloma, Mayo Clin Proc, 78, 21, 10.4065/78.1.21 Pepys, 2003, C-reactive protein: a critical update, J Clin Invest, 111, 1805, 10.1172/JCI200318921 Lauta, 2003, A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications, Cancer, 97, 2440, 10.1002/cncr.11072 McMillan, 2013, The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer, Cancer Treat Rev, 39, 534, 10.1016/j.ctrv.2012.08.003 Dupire, 2012, Prognostic value of PINI index in patients with multiple myeloma, Eur J Haematol, 88, 306, 10.1111/j.1600-0609.2011.01740.x Hutchison, 2007, Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies, J Am Soc Nephrol, 18, 886, 10.1681/ASN.2006080821 Winearls, 1995, Acute myeloma kidney, Kidney Int, 48, 1347, 10.1038/ki.1995.421 Hutchison, 2008, European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial, Trials, 9, 55, 10.1186/1745-6215-9-55